Robert Voncken
Maastricht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert Voncken.
Medical Physics | 2013
Skadi van der Meer; Esther J. Bloemen-van Gurp; Jolanda Hermans; Robert Voncken; Denys Heuvelmans; Carol Gubbels; Davide Fontanarosa; Peter Visser; Ludy Lutgens; Francis van Gils; Frank Verhaegen
PURPOSE A quantitative 3D intramodality ultrasound (US) imaging system was verified for daily in-room prostate localization, and compared to prostate localization based on implanted fiducial markers (FMs). METHODS Thirteen prostate patients underwent multiple US scans during treatment. A total of 376 US-scans and 817 matches were used to determine the intra- and interoperator variability. Additionally, eight other patients underwent daily prostate localization using both US and electronic portal imaging (EPI) with FMs resulting in 244 combined US-EPI scans. Scanning was performed with minimal probe pressure and a correction for the speed of sound aberration was performed. Uncertainties of both US and FM methods were assessed. User variability of the US method was assessed. RESULTS The overall US user variability is 2.6 mm. The mean differences between US and FM are: 2.5 ± 4.0 mm (LR), 0.6 ± 4.9 mm (SI), and -2.3 ± 3.6 mm (AP). The intramodality character of this US system mitigates potential errors due to transducer pressure and speed of sound aberrations. CONCLUSIONS The overall accuracy of US (3.0 mm) is comparable to our FM workflow (2.2 mm). Since neither US nor FM can be considered a gold standard no conclusions can be drawn on the superiority of either method. Because US imaging captures the prostate itself instead of surrogates no invasive procedure is required. It requires more effort to standardize US imaging than FM detection. Since US imaging does not involve a radiation burden, US prostate imaging offers an alternative for FM EPI positioning.
Physics in Medicine and Biology | 2017
Gabriel P. Fonseca; Mark Podesta; Murillo Bellezzo; Michiel R Van den Bosch; Ludy Lutgens; Ben G. L. Vanneste; Robert Voncken; Evert J. Van Limbergen; Brigitte Reniers; Frank Verhaegen
Brachytherapy is employed to treat a wide variety of cancers. However, an accurate treatment verification method is currently not available. This study describes a pre-treatment verification system that uses an imaging panel (IP) to verify important aspects of the treatment plan. A detailed modelling of the IP was only possible with an extensive calibration performed using a robotic arm. Irradiations were performed with a high dose rate (HDR) 192Ir source within a water phantom. An empirical fit was applied to measure the distance between the source and the detector so 3D Cartesian coordinates of the dwell positions can be obtained using a single panel. The IP acquires 7.14 fps to verify the dwell times, dwell positions and air kerma strength (Sk). A gynecological applicator was used to create a treatment plan that was registered with a CT image of the water phantom used during the experiments for verification purposes. Errors (shifts, exchanged connections and wrong dwell times) were simulated to verify the proposed verification system. Cartesian source positions (panel measurement plane) have a standard deviation of about 0.02 cm. The measured distance between the source and the panel (z-coordinate) have a standard deviation up to 0.16 cm and maximum absolute error of ≈0.6 cm if the signal is close to sensitive limit of the panel. The average response of the panel is very linear with Sk. Therefore, Sk measurements can be performed with relatively small errors. The measured dwell times show a maximum error of 0.2 s which is consistent with the acquisition rate of the panel. All simulated errors were clearly identified by the proposed system. The use of IPs is not common in brachytherapy, however, it provides considerable advantages. It was demonstrated that the IP can accurately measure Sk, dwell times and dwell positions.
Physics in Medicine and Biology | 2017
Gabriel P. Fonseca; Michiel R Van den Bosch; Robert Voncken; Mark Podesta; Frank Verhaegen
A novel system was developed to improve commissioning and quality assurance of brachytherapy applicators used in high dose rate (HDR). It employs an imaging panel to create reference images and to measure dwell times and dwell positions. As an example: two ring applicators of the same model were evaluated. An applicator was placed on the surface of an imaging panel and a HDR 192Ir source was positioned in an imaging channel above the panel to generate an image of the applicator, using the gamma photons of the brachytherapy source. The applicator projection image was overlaid with the images acquired by capturing the gamma photons emitted by the source dwelling inside the applicator. We verified 0.1, 0.2, 0.5 and 1.0 cm interdwell distances for different offsets, applicator inclinations and transfer tube curvatures. The data analysis was performed using in-house developed software capable of processing the data in real time, defining catheters and creating movies recording the irradiation procedure. One applicator showed up to 0.3 cm difference from the expected position for a specific dwell position. The problem appeared intermittently. The standard deviations of the remaining dwell positions (40 measurements) were less than 0.05 cm. The second ring applicator had a similar reproducibility with absolute coordinate differences from expected values ranging from -0.10 up to 0.18 cm. The curvature of the transfer tube can lead to differences larger than 0.1 cm whilst the inclination of the applicator showed a negligible effect. The proposed method allows the verification of all steps of the irradiation, providing accurate information about dwell positions and dwell times. It allows the verification of small interdwell positions (⩽0.1 cm) and reduces measurement time. In addition, no additional radiation source is necessary since the HDR 192Ir source is used to generate an image of the applicator.
Medical Physics | 2011
Skadi van der Meer; E Bloemen; Jolanda Hermans; Robert Voncken; Denys Heuvelmans; Carol Gubbels; M Berbee; E Seravalli; Peter Visser; Ludy Lutgens; Francis van Gils; Frank Verhaegen
Purpose: Image Guided Radiotherapy(IGRT) is a necessity for accurate radiotherapy.Ultrasound(US)imaging is a frequently used diagnostic technique for qualitative imaging of soft tissues. Recently, a quantitative 3D US system was introduced (Clarity system, Resonant Medical, Canada) which can assess the position of soft tissue in absolute space. Before introducing the device into daily practice, user variability, during both image acquisition and matching procedures must be determined. In this study we determined the inter‐ and intra‐operator variability of 3D US matching in prostate cancer patients. Moreover, we studied the influence of the scan variability on patient setup corrections, and the influence of probe pressure on the prostate position while using a strict bladder filling protocol. Methods: For 12 prostate patients multiple US scans are acquired by one or two operators during treatment. The repeated scans are matched to the reference US‐scan by a single user (variability for scanning). The remaining scans are matched three times by different users, and for each patient one single scan is matched five times by the same user (variability for matching). Results: In all three directions the mean intra‐operator difference ranges from 1.5 to 2.4 mm, with a standard deviation of approximately 1.7 mm. The mean inter‐operator difference is of the same order, 1.7 to 2.3 ± 1.8 mm. The prostate displacement due to the probe pressure varies from patient to patient and is not limited to one direction. Only the superior/inferior displacement seemed significant for high pressure, which was not needed to obtain good image quality with our bladder filling protocol. The total uncertainty is conservatively estimated to be 4 mm. Conclusions: The uncertainty of the 3D USIGRT system is comparable to the uncertainty of the current standard IGRT for prostate: electronic portal imager in combination with fiducial markers.
Radiotherapy and Oncology | 2018
Gabriel P. Fonseca; M.R. Van den Bosch; Robert Voncken; Mark Podesta; Frank Verhaegen
Radiotherapy and Oncology | 2018
Gabriel P. Fonseca; Mark Podesta; Robert Voncken; M.R. Van den Bosch; Ben G. L. Vanneste; Ludy Lutgens; Frank Verhaegen
Radiotherapy and Oncology | 2018
M. A. A. J. van den Bosch; Gabriel P. Fonseca; Robert Voncken; Murillo Bellezzo; Frank Verhaegen
Brachytherapy | 2018
Murillo Bellezzo; Gabriel P. Fonseca; An-Sofie Verrijssen; Robert Voncken; Michiel R Van den Bosch; Hélio Yoriyaz; Brigitte Reniers; Maaike Berbée; Evert J. Van Limbergen; Frank Verhaegen
Radiotherapy and Oncology | 2017
M. A. A. J. van den Bosch; Ben G. L. Vanneste; Robert Voncken; Ludy Lutgens
Radiotherapy and Oncology | 2011
S. van der Meer; E. Bloemen-van Gurp; Jolanda Hermans; Denys Heuvelmans; Robert Voncken; C. Grubbels; M. Berbée; Enrica Seravalli; Peter Visser; Ludy Lutgens; F. van Gils; Frank Verhaegen